http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105837681-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate | 2015-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105837681-B |
| titleOfInvention | A kind of Erythropoietin mimetic peptide derivative, preparation method and use |
| abstract | The present invention relates to a kind of Erythropoietin mimetic peptide derivative and its officinal salt with long-acting promoting erythrocyte systematic function.The present invention also provides the preparation method of above-mentioned Erythropoietin mimetic peptide derivative and its be used to prepare treatment by lack red blood cell lack erythropoietin(EPO) or red cell population lack or defect characterized by disease drug in purposes.Wherein, Erythropoietin mimetic peptide derivative provided by the invention monomeric peptide as shown in SEQ ID NO:1 or the polymer formed by lysine (K) side chain free amine group of monomeric peptide end；Wherein, two cysteines of each monomeric peptide form disulfide bond in the polymer, and the number of monomeric peptide is 2-10 in the polymer. |
| priorityDate | 2015-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 222.